TITLE:
Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

CONDITION:
Skin/Soft Tissue Infections

INTERVENTION:
linezolid

SUMMARY:

      To determine if linezolid is superior to vancomycin in the treatment of complicated skin and
      soft tissue infections due to MRSA in adult subjects
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Male and female subjects with signs or symptoms consistent with infection, and if
             available, laboratory findings consistent with staphylococcal infection (e.g., Gram
             stain and culture results).

          -  Signs and symptoms consistent with infection

          -  Infection suspected to be due to Methicillin Resistant Staphylococcus Aureus

        Exclusion Criteria:

          -  Subjects who were treated with a previous antibiotic (systemic or topical) with MRSA
             activity (other than linezolid or vancomycin) for more than 24 hours and treatment
             extended into the 72 hour period prior to the first dose of study drug, unless
             documented to be a treatment failure (72 hours of treatment and not responding).

          -  Subjects with uncomplicated skin or superficial skin structure infection such as
             superficial/simple cellulitis, impetiginous lesion, furuncle, or simple abscess that
             only need surgical drainage for cure.

          -  Subjects excluded with necrotizing fasciitis, gas gangrene, osteomyelitis
      
